COMPANY PROFILE

Novo Nordisk - ADR

Chart
Overview
Financials

Related Articles

Michael McTague: The pharmaceutical giants leading the market-cap parade in 2025
The health-care stocks to watch as treatment innovations shake up patient care
Why weight-loss drugs are the top target of Medicare price negotiations
Michael McTague: 5 key pharmaceutical trends that will carry into 2025
Roche shifts toward obesity medication
10 large corporations standing by the LGBTQ+ community every day of the year
Obesity, oncology and old age: How 2023 pharmaceutical M&A is reshaping the health-care industry
Truly Transformative: AI in Biotech, Biologics for Weight Loss and, Yes, The Sphere